HK Stock MarketDetailed Quotes

KEYMED BIO-B (02162)

Watchlist
  • 73.050
  • -0.500-0.68%
15min DelayMarket Closed Sep 11 16:02 CST
21.82BMarket Cap24.50P/E (TTM)

KEYMED BIO-B (02162) Earnings Dates, Reports & Conference Call

02162 2026 H1 Earnings Dates & Summary

Currency:CNYAug 19, 2026

Estimate
(YoY)
Actual
(YoY)
Vs Estimate
(% Chg)
Revenue
615.56M
617.07M
+1.51M
Beat Est.
+0.24%
Net Income
--
1.22B
--
+1645.21%
Strong Buy

Sep 11, 2026

02162 Revenue, EPS and EBIT Estimates

Revenue

Net Profit

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2027/H1-- / 885.231M--
--2026/H2-- / 555.677M--
Aug 19, 20262026/H1617.068M / 615.560M--
Mar 26, 20262025/H2217.561M / 338.425M--
Aug 26, 20252025/H1-- / 498.752M--
DatePeriodRevenue/EstimateEarnings Call
--2027/H1-- / 885.231M--
--2026/H2-- / 555.677M--
Aug 19, 20262026/H1617.068M / 615.560M--
Mar 26, 20262025/H2217.561M / 338.425M--
Aug 26, 20252025/H1-- / 498.752M--

Unlock Free Earnings Estimates

Market Insights
China and the US begin implementing the Kuala Lumpur economic and trade consultation consensus.
China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome Show More